Matches in Nanopublications for { ?s ?p "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP829275.RAVGC-zOKe5csX9Kny3fZSdggCILtuzDw47WUmU3cKW-I130_assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829275.RAVGC-zOKe5csX9Kny3fZSdggCILtuzDw47WUmU3cKW-I130_provenance.
- assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1126825.RAo86hPQKMxgmaw0mBkKmGFSjJLpAftEMB6HpZL1NmEYk130_assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126825.RAo86hPQKMxgmaw0mBkKmGFSjJLpAftEMB6HpZL1NmEYk130_provenance.
- NP396032.RA1xwyeQiP8y5AIxtYiZkf4vhQHRgA60Eg-ozHDa7cBbo130_assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396032.RA1xwyeQiP8y5AIxtYiZkf4vhQHRgA60Eg-ozHDa7cBbo130_provenance.
- NP1126826.RAG0G1H70oYfGDa2ONMRf7gv4XK0dT4inISRrqZefHozU130_assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126826.RAG0G1H70oYfGDa2ONMRf7gv4XK0dT4inISRrqZefHozU130_provenance.
- NP978340.RA0L6EXtdmiu6OGkac44_olt7sPre_QLETfou-C7AuuRE130_assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978340.RA0L6EXtdmiu6OGkac44_olt7sPre_QLETfou-C7AuuRE130_provenance.
- NP1126827.RA1oFGrwebeGXXfkQf_HDyNeMccdBtV38S7TIMkp3LguQ130_assertion description "[Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill-Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF-? signaling mediated through mutations in FBN1 or ADAMTSL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126827.RA1oFGrwebeGXXfkQf_HDyNeMccdBtV38S7TIMkp3LguQ130_provenance.